Dr. Peter Yamoah is a registered Ghanaian pharmacist who teaches and practices pharmacy in both clinic and academic settings. He has over 17 years of hospital, academic, community and regulatory practice experience.
He completed his bachelor of pharmacy degree at KNUST. Before sitting for his pharmacy professional qualifying exams, he completed a certificate course in Management of Drug Supplies which was a professional development program organized by the Commonwealth Pharmaceutical Association and the Robert Gordon University, Aberdeen, Scotland.
After joining the Komfo Anokye Teaching Hospital and demonstrating high clinical research potential, Dr. Yamoah was sponsored to pursue a professional diploma in project design and management at the Liverpool School of Tropical Medicine, UK. He furthered his education specializing in clinical research at the Masters level and pharmacovigilance at the PhD level at the University of Liverpool, UK and University of KwaZulu-Natal, South Africa respectively.
Dr. Yamoah has been a patient safety advocate particularly publishing and speaking at international conferences on vaccine safety. He is a fellow of the Africa Collaborating Centre for Advocacy and Training in Pharmacovigilance, Ghana. He consults for various pharmaceutical companies on drug regulation, patient safety and clinical trials.
He is currently a lecturer at the department of pharmacy practice, University of Health and Allied Sciences, Ghana where he is involved in the clinical training of PharmD graduates, teaching courses including pharmacovigilance, clinical pharmacokinetics and therapeutic drug monitoring, public health, pharmacoepidemiology, evidence-based medicine and pathophysiology and therapeutics.
Furthermore, he is a pharmacovigilance research associate at the University of KwaZulu-Natal, South Africa. Additionally, he is part of a team of Ghanaian scientists studying the early detection and diagnosis of transthyretin amyloidosis in Ghana.